Literature DB >> 24651826

Single- and multiple-dose pharmacokinetics and total removal of colistin in a patient with acute kidney injury undergoing extended daily dialysis.

Ann-Kathrin Strunk1, Julius J Schmidt1, Eva Baroke2, Stefanie M Bode-Böger3, Jens Martens-Lobenhoffer3, Tobias Welte2, Jan T Kielstein4.   

Abstract

Entities:  

Keywords:  CMS; PK; colistin methanesulfonate; renal replacement therapy

Mesh：

Substances：

Year:  2014        PMID： 24651826     DOI： 10.1093/jac/dku075

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

Review 1.  A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy.

Authors:  Valentina Pistolesi; Santo Morabito; Francesca Di Mario; Giuseppe Regolisti; Chiara Cantarelli; Enrico Fiaccadori
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  [Drug dosing in extracorporeal therapy].

Authors:  J T Kielstein
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-05-22       Impact factor: 0.840

3.  Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.

Authors:  Kevin S Akers; Matthew P Rowan; Krista L Niece; Ian J Stewart; Katrin Mende; Jason M Cota; Clinton K Murray; Kevin K Chung
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

4.  Dosing guidance for intravenous colistin in critically-ill patients.

Authors:  Roger L Nation; Samira M Garonzik; Visanu Thamlikitkul; Evangelos J Giamarellos-Bourboulis; Alan Forrest; David L Paterson; Jian Li; Fernanda P Silveira
Journal:  Clin Infect Dis       Date:  2016-12-23       Impact factor: 9.079

5.  Survey of pharmacists’ antibiotic dosing recommendations for sustained low-efficiency dialysis.

Authors:  Jian P Mei; Azadeh Ali-Moghaddam; Bruce A Mueller
Journal:  Int J Clin Pharm       Date:  2016-02

6.  Efficient removal of colistin A and B in critically ill patients undergoing CVVHDF and sorbent technologies.

Authors:  Filippo Mariano; Marta Leporati; Paola Carignano; Maurizio Stella; Marco Vincenti; Luigi Biancone
Journal:  J Nephrol       Date:  2014-09-24       Impact factor: 3.902

7.  International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

Authors:  Brian T Tsuji; Jason M Pogue; Alexandre P Zavascki; Mical Paul; George L Daikos; Alan Forrest; Daniele R Giacobbe; Claudio Viscoli; Helen Giamarellou; Ilias Karaiskos; Donald Kaye; Johan W Mouton; Vincent H Tam; Visanu Thamlikitkul; Richard G Wunderink; Jian Li; Roger L Nation; Keith S Kaye
Journal:  Pharmacotherapy       Date:  2019-01       Impact factor: 6.251

Review 8.  Antibiotic Dosing in Sustained Low-Efficiency Dialysis in Critically Ill Patients.

Authors:  Sidharth Kumar Sethi; Vinod Krishnappa; Nisha Nangethu; Paul Nemer; Lawrence A Frazee; Rupesh Raina
Journal:  Can J Kidney Health Dis       Date:  2018-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.